Regarding metabolic side effects, considering the dosage of quetiapine in our hospital (at the time of discharge, 13 of 14 patients were under 50 mg/day), the effect of multiple receptor blockade with quetiapine may not be significant. 10 , 11 BZD/non‐BZD is a risk factor for falls, cognitive impairment, and delirium. 12 , 13 , 14 It is reported that BZD/non‐BZD could cause dependence within months, even with regular doses. 15 Additionally, another study reported that BZD/non‐BZD can be reduced at a relatively high rate, discontinued, or switched to lemborexant, which is considered less risky. 16 Therefore, early reduction or discontinuation (including switching) of BZD/non‐BZD may be beneficial.
1
—
—